ENHANCEMENT OF NORADRENALINE RELEASE FROM RAT CEREBRAL-CORTEX BY NEUROLEPTIC DRUGS

被引:26
作者
GROSS, G [1 ]
SCHUMANN, HJ [1 ]
机构
[1] UNIV ESSEN GESAMTHSCH,INST PHARMAKOL,D-4300 ESSEN 1,FED REP GER
关键词
D O I
10.1007/BF00499252
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:103 / 109
页数:7
相关论文
共 33 条
[1]   RECEPTOR ACTIVITY AND TURNOVER OF DOPAMINE AND NORADRENALINE AFTER NEUROLEPTICS [J].
ANDEN, NE ;
BUTCHER, SG ;
CORRODI, H ;
FUXE, K ;
UNGERSTEDT, U .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 11 (03) :303-+
[2]   NEUROLEPTIC BINDING AND THEIR EFFECTS ON SPONTANEOUS AND POTASSIUM-EVOKED RELEASE OF DOPAMINE-H-3 FROM STRIATUM AND OF H-3-NORADRENALINE FROM CEREBRAL-CORTEX [J].
ARBILLA, S ;
BRILEY, MS ;
DUBOCOVICH, ML ;
LANGER, SZ .
LIFE SCIENCES, 1978, 23 (17-1) :1775-1780
[3]   EFFECT OF NEUROLEPTICS ON ENDOGENOUS NOREPINEPHRINE IN RAT-BRAIN [J].
BARTHOLINI, G ;
KELLER, HH ;
PLETSCHER, A .
NEUROPHARMACOLOGY, 1973, 12 (08) :751-756
[4]   BLOCKADE OF PRESYNAPTIC ALPHA-RECEPTORS AND OF AMINE UPTAKE IN RAT-BRAIN BY ANTIDEPRESSANT MIANSERINE [J].
BAUMANN, PA ;
MAITRE, L .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 300 (01) :31-37
[5]  
BENKERT O, 1980, PSYCHIATRISCHE PHARM
[6]   NORADRENERGIC CYCLIC-AMP GENERATING SYSTEM IN LIMBIC FOREBRAIN - PHARMACOLOGICAL CHARACTERIZATION INVITRO AND POSSIBLE ROLE OF LIMBIC NORADRENERGIC MECHANISMS IN MODE OF ACTION OF ANTIPSYCHOTICS [J].
BLUMBERG, JB ;
VETULANI, J ;
STAWARZ, RJ ;
SULSER, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 37 (02) :357-366
[7]   COMPARISON OF PRESYNAPTIC AND POSTSYNAPTIC EFFECTS OF ALPHA-ADRENOLYTIC DRUGS IN PULMONARY-ARTERY OF RABBIT [J].
BOROWSKI, E ;
STARKE, K ;
EHRL, H ;
ENDO, T .
NEUROSCIENCE, 1977, 2 (02) :285-296
[8]   EFFECTS OF CLOZAPINE, THIORIDAZINE, PERLAPINE AND HALOPERIDOL ON METABOLISM OF BIOGENIC-AMINES IN BRAIN OF RAT [J].
BURKI, HR ;
RUCH, W ;
ASPER, H .
PSYCHOPHARMACOLOGIA, 1975, 41 (01) :27-33
[9]   EXAMINATION OF THE NEGATIVE FEEDBACK FUNCTION OF PRESYNAPTIC ADRENOCEPTORS IN A VASCULAR TISSUE [J].
CHAN, CC ;
KALSNER, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1979, 67 (03) :401-407
[10]  
CREESE I, 1978, PSYCHOPHARMACOLOGY G, P377